3 Top Biotech Stocks You Shouldn't Ignore
StockNews
Published Apr 15, 2021 10:48AM ET
Updated Apr 15, 2021 12:31PM ET
3 Top Biotech Stocks You Shouldn't Ignore
The biotech industry got a huge boost last year as companies scrambled to find treatments and vaccines for COVID-19. After hitting a high in February, the industry fell back as cyclical stocks came into play. But now that an economic recovery is already priced into the market, undervalued biotech stocks such as Amgen (AMGN), Gilead Sciences (NASDAQ:GILD), and Vertex Pharmaceuticals (NASDAQ:VRTX) should share their shares rise in the months ahead.The biotech industry is composed of companies that develop drugs and other treatments for viruses, medical conditions, and diseases. The industry has seen its share of losses over the past couple of months but that provides us the perfect opportunity to pick up shares of stocks that could see substantial gains in the months ahead.
The biotech industry hit a high point in early February after seeing huge gains in 2020. The recent pullback results from a rotation into cyclical stocks, worries over drug-pricing reforms, and delayed drug approvals. I believe that these worries are overblown, and we can use them to our advantage. Any optimism over our economy's gradual opening is already priced into cyclical stocks, and investors will now be looking for shares with lower valuations.
Plus, any worries over potential Congressional legislation on drug pricing are misplaced. The chances of anything getting passed are slim. And the three stocks I will focus on in this article won't be affected by FDA delays on approvals. They are Amgen Inc . (NASDAQ:AMGN), Gilead Sciences, Inc. (GILD), and Vertex Pharmaceuticals Incorporated (VRTX). These three biotech stocks are poised to see their shares rise in the months ahead.
Continue reading on StockNews
Get The News You Want
Written By: StockNews
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.